Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions
Akihito Oya(Keio University), Takeshi Miyamoto(Kumamoto Health Science University), Mayu Morita(Keio University), Masaya Nakamura(Keio University), Takashi Kobayashi(Oita University), Eri Katsuyama(Okayama University of Science), Atsushi Funayama(Keio University), Toru Nishiwaki(Keio University), Tami Kobayashi(Keio University), Morio Matsumoto(Keio University Hospital), Yoshinari Fujita(Keio University), Arihiko Kanaji(Fujita Health University), Yuiko Sato(Keio University), Kana Miyamoto(Kumamoto University)
Cited by 17
Related Papers
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694
v-ATPase V0 subunit d2–deficient mice exhibit impaired osteoclast fusion and increased bone formation
|Nature Medicine|2006|542
Foxp3 Inhibits RORγt-mediated IL-17A mRNA Transcription through Direct Interaction with RORγt*
|Journal of Biological Chemistry|2008|433